Jun 07, 2023 / 05:30PM GMT
Mike Yee - Jefferies - Analyst
We are very fortunate to have the CEO of Kodiak up here with us on a fireside chat. Kodiak, if you haven't been paying attention, has major Phase 3 data coming up for their lead program in retinal diseases. And it feels like people are starting to get focused and get engaged, Victor.
Questions and Answers:
Mike Yee - Jefferies - AnalystSo I would love for you to maybe just make some opening comments about the state of affairs with your program and what data is coming up. And why you feel excited about where Kodiak is today?
Victor Perlroth - Kodiak Sciences Inc. - Chairman & CEO
Thanks a lot, Mike. Can you hear me?
Mike Yee - Jefferies - Analyst
Yeah.
Victor Perlroth - Kodiak Sciences Inc. - Chairman & CEO
It's a pleasure to be here. Thanks, everyone. See if we have the presentation, too.
Mike Yee - Jefferies - Analyst
And if we if we don't